Welcome to the International AIDS Society-USA

Publications/Guidelines

Topics in HIV Medicine®
2008 ISSUE

December 2008 (Volume 16, Issue 5)
Download the entire issue here or select individual articles below.

Special Contribution

Update of the Drug Resistance Mutations in HIV-1: December 2008
International AIDS Society-USA Drug Resistance Mutations Group

Perspectives

Drug-Drug Interactions With Newer Antiretroviral Agents
Judith A. Aberg, MD
Methicillin-Resistance Staphylococcus aureus Infections
John G. Bartlett, MD
Improving Engagement in HIV Care: What Can We Do?
Michael J. Mugavero, MD, MHSc

October/November 2008 (Volume 16, Issue 4)
Download the entire issue here or select individual articles below.

Perspectives

Emerging Resistance Profiles of Newly Approved Antiretroviral Drugs
Eric S. Daar, MD
Non-AIDS Defining Malignancies in HIV
Ronald T. Mitsuyasu, MD
Renal Dysfunction and Tenofovir Toxicity in HIV-infected Patients
Lynda A. Szczech, MD, MSCE
Pathogenesis and Treatment of Lipodystrophy: What Clinicians Need to Know
Fred R. Sattler, MD

Reprint

Antiretroviral Treatment of Adult HIV Infection: 2008 Recommendations of the International AIDS Society-USA Panel
Hammer et al. JAMA. 2008;300:555-570

August/September (Volume 16, Issue 3)
This issue contains a reprint of an article on updated recommendations for resistance testing in HIV infection. This paper was developed by a volunteer panel convened by the International AIDS Society-USA of physicians and scientists with expertise in drug-resistant HIV-1, drug management, and patient care. The new guidelines, published in the July 15, 2008, issue of Clinical Infectious Diseases, were necessitated by the availability of new drugs from various classes, the standardization of resistance assays, and the development of viral tropism tests.

Reprint

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA
Hirsch MS et al. CID. 2008;47:266-286

June/July 2008 (Volume 16, Issue 2)
Download the entire issue here or select individual articles below.

Perspectives

When to Start Antiretroviral Therapy: A Swinging Pendulum?
Joel E. Gallant, MD, MPH
Insulin Resistance in HIV Infection: Drugs, Host Responses, Or Restoration to Health?
Carl Grunfeld, MD, PhD
HIV-Associated Neurocognitive Disease Continues in the Antiretroviral Era (Web version as corrected July 8, 2009)
David B. Clifford, MD

Commentary

Impact of Psychiatric Disorders on the HIV Epidemic
Andrew F. Angelino, MD

April/May 2008 (Volume 16, Issue 1)
Download the entire issue here or select individual articles below.

Highlights of the 15th Conference on Retroviruses and Opportunistic Infections

Basic Science Summary
Mario Stevenson, PhD
Basic HIV Vaccine Development
David I. Watkins, PhD
HIV Testing and Prevention Strategies
Susan Buchbinder, MD
Neurologic Complications of HIV Disease and Their Treatment
Scott Letendre, MD, J. Allen McCutchan, MD, MSc, and Ronald J. Ellis, MD, PhD
Complications of HIV Disease and Therapy
Judith S. Currier, MD, and Diane V. Havlir, MD
Advances in Antiretroviral Therapy
Timothy J. Wilkin, MD, MPH, Barbara Taylor, MD, Susan Olender, MD, and Scott M. Hammer, MD

Special Contribution

Update of the Drug Resistance Mutations in HIV-1: Spring 2008
International AIDS Society-USA Drug Resistance Mutations Group

Return to Top